Publications of Mark B McClellan    :chronological  alphabetical  combined  bibtex listing:

We've launched a new site so please go to People & Research for current information on our faculty and staff.

Books

  1. Dzau, VJ; McClellan, MB; McGinnis, JM; Finkelman, EM. Vital directions for health & health care: An initiative of the national academy of medicine. September, 2023. 1-471 pp. [doi]  [abs]
  2. Dzau, VJ; McClellan, MB. Preface. September, 2023. ix-xi pp.

Journal Articles

  1. Pencina, MJ; Silcox, C; Economou-Zavlanos, N; McClellan, M. "Bridging the Gap Between Developers and Implementers in Health AI.." JAMA Health Forum 6.6 (June, 2025): e251692. [doi]
  2. Gottlieb, S; McClellan, MB. "Why a Planned Reorganization of the FDA Creates Major Challenges.." JAMA health forum 6.5 (May, 2025): e252326. [doi]
  3. Shapiro, LM; Bozic, KJ; McClellan, M; Spindler, K. "The New Centers for Medicare and Medicaid Services Patient-Reported Outcome-Based Performance Measure: What It Means and How Can I Align.." The Journal of the American Academy of Orthopaedic Surgeons 33.10 (May, 2025): e541-e550. [doi]  [abs]
  4. Nafie, M; Parker, VJ; McClellan, M; Hendricks-Sturrup, RM. "A Brief Report on Proposed Areas of International Harmonization of Real-World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators.." Pharmacoepidemiology and drug safety 34.3 (March, 2025): e70127. [doi]  [abs]
  5. Yan, Q; McClellan, M; Liu, GG; Orlins, S; Gao, GF. "Forging paths together: The history of U.S.-China Track II Health Dialogue and the future of Chinese-American health communication." Hlife 3.2 (February, 2025): 57-60. [doi]
  6. McClellan, M; DeSalvo, KB; Benjamin, GC; Cerise, FP; Choucair, B; Del Rio, C; Harrison, M; Medows, R; Ranney, ML; Zink, A. "Updating US Public Health For Healthier Communities.." Health affairs (Project Hope) 44.2 (February, 2025): 148-155. [doi]  [abs]
  7. McClellan, M. "Health Care Policy: Making the Case for Government Regulation." Nejm Catalyst Innovations in Care Delivery 5.11 (November, 2024). [doi]  [abs]
  8. Kehoe, L; Locke, T; McClellan, M; Landray, M; Hernandez, A; Okun, S. "Overcoming the barriers to better evidence generation from clinical trials.." Trials 25.1 (September, 2024): 614. [doi]  [abs]
  9. Hamilton Lopez, M; McClellan, MB; Daniel, G. "Perspectives on Improving Value Assessment With the ISPOR SUITABILITY Checklist.." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27.6 (June, 2024): 687-688. [doi]
  10. Gottlieb, S; McClellan, MB. "Bolstering FDA Pathways for Reducing Death and Disease from Tobacco.." JAMA health forum 5.4 (April, 2024): e241233. [doi]
  11. Silcox, C; Zimlichmann, E; Huber, K; Rowen, N; Saunders, R; McClellan, M; Kahn, CN; Salzberg, CA; Bates, DW. "The potential for artificial intelligence to transform healthcare: perspectives from international health leaders.." NPJ digital medicine 7.1 (April, 2024): 88. [doi]  [abs]
  12. Volpp, KG; Berkowitz, SA; Sharma, SV; Anderson, CAM; Brewer, LC; Elkind, MSV; Gardner, CD; Gervis, JE; Harrington, RA; Herrero, M; Lichtenstein, AH; McClellan, M; Muse, J; Roberto, CA; Zachariah, JPV; American Heart Association. "Food Is Medicine: A Presidential Advisory From the American Heart Association.." Circulation 148.18 (October, 2023): 1417-1439. [doi]  [abs]
  13. Gonzalez-Smith, J; Salzberg, C; Smith, M; Saunders, R; Mcclellan, M; Kahn, CH; Tabb, K; Zimlichman, E. "Advancing the Future of "Care Without an Address": Recommendations from International Health Care Leaders." Nejm Catalyst Innovations in Care Delivery 28 (July, 2023): 301-308. [doi]  [abs]
  14. Golla, V; Scales, CD; Johnson, D; Kaplan, AL; Stimson, CJ; McClellan, M; Saunders, R. "Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers.." Urology 171 (January, 2023): 1-5. [doi]
  15. Gottlieb, S; McClellan, MB. "Reforms Needed to Modernize the US Food and Drug Administration's Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests." JAMA Health Forum 3.10 (October, 2022): E224449. [doi]
  16. Arad, N; Kroetsch, A; McClellan, M. "Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability".." Clinical pharmacology and therapeutics 112.1 (July, 2022): 25-27. [doi]
  17. Japinga, M; Bartz, A; Saunders, R; McClellan, M. "Health Policy Priorities for the Biden Administration.." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20.3 (March, 2022): 477-480. [doi]
  18. Mahendraratnam, N; Mercon, K; Gill, M; Benzing, L; McClellan, MB. "Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.." Clinical pharmacology and therapeutics 111.1 (January, 2022): 150-154. [doi]  [abs]
  19. Kaufman, BG; Whitaker, R; Mahendraratnam, N; Hurewitz, S; Yi, J; Smith, VA; McClellan, M. "State variation in effects of state social distancing policies on COVID-19 cases.." BMC Public Health 21.1 (June, 2021): 1239. [doi]  [abs]
  20. Japinga, M; Singletary, E; McClellan, M. "How Telehealth Expansion Can Support Comprehensive Virtual Care." Nejm Catalyst Innovations in Care Delivery 2.7 (June, 2021). [doi]  [abs]
  21. Nussbaum, DP; Rushing, CN; Sun, Z; Yerokun, BA; Worni, M; Saunders, RS; McClellan, MB; Niedzwiecki, D; Greenup, RA; Blazer, DG. "Hospital-level compliance with the commission on cancer's quality of care measures and the association with patient survival.." Cancer Med 10.11 (June, 2021): 3533-3544. [doi]  [abs]
  22. Kaufman, BG; Anderson, D; Bleser, WK; Muhlestein, DB; Smith, N; Clough, J; McClellan, MB; Saunders, R. "Association of ACO Shared Savings Success and Serious Illness Spending.." J Healthc Manag 66.3 (May, 2021): 227-240. [doi]  [abs]
  23. Dzau, VJ; McClellan, MB; McGinnis, JM; Marx, JC; Sullenger, RD; ElLaissi, W. "Vital Directions For Health And Health Care: Priorities For 2021.." Health Aff (Millwood) 40.2 (February, 2021): 197-203. [doi]  [abs]
  24. Schmidt, T; Valuck, T; Perkins, B; Riposo, J; Patel, P; Westrich, K; Basch, E; McClellan, M. "Improving patient-reported measures in oncology: a payer call to action.." Journal of managed care & specialty pharmacy 27.1 (January, 2021): 118-126. [doi]  [abs]
  25. Kaufman, BG; Whitaker, R; Mahendraratnam, N; Smith, VA; McClellan, MB. "Comparing Associations of State Reopening Strategies with COVID-19 Burden.." J Gen Intern Med 35.12 (December, 2020): 3627-3634. [doi]  [abs]
  26. Kaufman, BG; Bleser, WK; Saunders, R; Anderson, D; Van Houtven, CH; Muhlestein, DB; Clough, J; McClellan, MB. "Prospective or retrospective ACO attribution matters for seriously ill patients.." Am J Manag Care 26.12 (December, 2020): 534-540. [doi]  [abs]
  27. Wang, GX; Frank, HR; Santanam, TS; Zeng, E; Vulimiri, M; McClellan, M; Wong, CA. "Pediatric accountable health communities: Insights on needed capabilities and potential solutions.." Healthcare (Amsterdam, Netherlands) 8.4 (December, 2020): 100481. [doi]  [abs]
  28. Kaufman, BG; Whitaker, R; Mahendraratnam, N; Smith, VA; McClellan, MB. "Correction to: Comparing Associations of State Reopening Strategies with COVID-19 Burden.." J Gen Intern Med (November, 2020): 1. [doi]  [abs]
  29. Sorenson, C; Japinga, M; Crook, H; McClellan, M. "Building A Better Health Care System Post-Covid-19: Steps for Reducing Low-Value and Wasteful Care." NEJM Catalyst (August, 2020).
  30. Psotka, MA; Singletary, EA; Bleser, WK; Roiland, RA; Hamilton Lopez, M; Saunders, RS; Wang, TY; McClellan, MB; Brown, N; American Heart Association Prior Authorization Learning Collaborative*. "Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative's Prior Authorization Learning Collaborative.." Circulation. Cardiovascular quality and outcomes 13.7 (July, 2020): e006564. [doi]  [abs]
  31. Hung, A; Schneider, M; Lopez, MH; McClellan, M. "Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials.." J Manag Care Spec Pharm 26.7 (July, 2020): 888-900. [doi]  [abs]
  32. Bufalino, VJ; Bleser, WK; Singletary, EA; Granger, BB; O'Brien, EC; Elkind, MSV; Hamilton Lopez, M; Saunders, RS; McClellan, MB; Brown, N; American Heart Association Predict & Prevent Learning Collaborative*. "Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action From the Value in Healthcare Initiative's Predict & Prevent Learning Collaborative.." Circ Cardiovasc Qual Outcomes 13.7 (July, 2020): e006780. [doi]  [abs]
  33. Warner, JJ; Crook, HL; Whelan, KM; Bleser, WK; Roiland, RA; Hamilton Lopez, M; Saunders, RS; Wang, TY; Hernandez, AF; McClellan, MB; Califf, RM; Brown, N; American Heart Association Partnering with Regulators Learning Collaborative*. "Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.." Circ Cardiovasc Qual Outcomes 13.7 (July, 2020): e006606. [doi]  [abs]
  34. Lopez, MH; Daniel, GW; Fiore, NC; Higgins, A; McClellan, MB. "Paying For Value From Costly Medical Technologies: A Framework For Applying Value-Based Payment Reforms.." Health affairs (Project Hope) 39.6 (June, 2020): 1018-1025. [doi]  [abs]
  35. McClellan, MB; Bleser, WK; Joynt Maddox, KE. "Advancing Value-Based Cardiovascular Care: The American Heart Association Value in Healthcare Initiative.." Circulation. Cardiovascular quality and outcomes 13.5 (May, 2020): e006610. [doi]
  36. Crook, H; Whitaker, R; Kim, A; Heiser, S; McClellan, MB. "North Carolina's Health Care Transformation to Value: Progress to Date and Further Steps Needed.." North Carolina medical journal 81.3 (May, 2020): 191-194. [doi]  [abs]
  37. Joynt Maddox, K; Bleser, WK; Crook, HL; Nelson, AJ; Hamilton Lopez, M; Saunders, RS; McClellan, MB; Brown, N; American Heart Association Value-Based Models Learning Collaborative. "Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative.." Circulation. Cardiovascular quality and outcomes 13.5 (May, 2020): e006483. [doi]  [abs]
  38. Crook, H; Whitaker, RG; Bleser, W; Saunders, R; McClellan, MB. "The Past Decade of Paying for Value: From the Affordable Care Act to COVID-19." North Carolina Medical Journal 81.6 (January, 2020): 381-385. [doi]  [abs]
  39. Joynt Maddox, KE; McClellan, MB. "Toward Evidence-Based Policy Making to Reduce Wasteful Health Care Spending.." JAMA 322.15 (October, 2019): 1460-1462. [doi]
  40. Moseley, CA; Vulimiri, M; Saunders, RS; Bleser, WK; Perrin, EM; Armstrong, SC; Wang, GX; Ubel, PA; McClellan, M; Wong, CA. "Medicaid and CHIP Child Health Beneficiary Incentives: Program Landscape and Stakeholder Insights.." Pediatrics 144.2 (August, 2019): e20183161. [doi]  [abs]
  41. Augustovski, F; McClellan, MB. "Current Policy and Practice for Value-Based Pricing.." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 22.6S (June, 2019): S4-S6. [doi]
  42. Bleser, WK; Saunders, RS; Winfield, L; Japinga, M; Smith, N; Kaufman, BG; Crook, HL; Muhlestein, DB; McClellan, M. "ACO Serious Illness Care: Survey And Case Studies Depict Current Challenges And Future Opportunities.." Health Aff (Millwood) 38.6 (June, 2019): 1011-1020. [doi]  [abs]
  43. Bleser, WK; Saunders, RS; Muhlestein, DB; McClellan, M. "Why Do Accountable Care Organizations Leave The Medicare Shared Savings Program?." Health affairs (Project Hope) 38.5 (May, 2019): 794-803. [doi]  [abs]
  44. Daniel, GW; Romine, MH; McClellan, MB. "Can Innovation in Regulatory Science Address Health Care Cost Burdens?." Clinical pharmacology and therapeutics 105.4 (April, 2019): 809-811. [doi]
  45. Volk, ML; Mellinger, J; Bansal, MB; Gellad, ZF; McClellan, M; Kanwal, F. "A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis.." Hepatology 69.3 (March, 2019): 1300-1305. [doi]  [abs]
  46. Parekh, N; McClellan, M; Shrank, WH. "Payment Reform, Medication Use, and Costs: Can We Afford to Leave Out Drugs?." Journal of general internal medicine 34.3 (March, 2019): 473-476. [doi]  [abs]
  47. Vulimiri, M; Bleser, WK; Saunders, RS; Madanay, F; Moseley, C; McGuire, HF; Ubel, PA; McKethan, A; McClellan, M; Wong, CA. "Engaging Beneficiaries In Medicaid Programs That Incentivize Health-Promoting Behaviors.." Health Aff (Millwood) 38.3 (March, 2019): 431-439. [doi]  [abs]
  48. McClellan, M; Brown, N; Califf, RM; Warner, JJ. "Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.." Circulation 139.9 (February, 2019): e44-e54. [doi]  [abs]
  49. Mahendraratnam, N; Sorenson, C; Richardson, E; Daniel, GW; Buelt, L; Westrich, K; Qian, J; Campbell, H; McClellan, M; Dubois, RW. "Value-based arrangements may be more prevalent than assumed.." Am J Manag Care 25.2 (February, 2019): 70-76.  [abs]
  50. McClellan, MB. "Inconsistent Reporting of Potential Conflicts of Interest in JAMA Pediatrics.." JAMA pediatrics 173.1 (January, 2019): 103-104. [doi]
  51. McClellan, MB. "Inconsistent Reporting of Potential Conflicts of Interest in JAMA Cardiology.." JAMA cardiology 4.1 (January, 2019): 84. [doi]
  52. Califf, RM; Hamburg, M; Henney, JE; Kessler, DA; McClellan, M; von Eschenbach, AC; Young, F. "Seven Former FDA Commissioners: The FDA Should Be An Independent Federal Agency.." Health Aff (Millwood) 38.1 (January, 2019): 84-86. [doi]  [abs]
  53. McClellan, MB. "Inconsistent Reporting of Potential Conflicts of Interest in JAMA.." JAMA 320.24 (December, 2018): 2601-2602. [doi]
  54. Zafar, SY; Polite, BN; McClellan, M. "Engaging Patients in Value-Based Cancer Care: A Missed Opportunity.." JAMA Oncol 4.11 (November, 2018): 1479-1480. [doi]
  55. Platt, R; Brown, JS; Robb, M; McClellan, M; Ball, R; Nguyen, MD; Sherman, RE. "The FDA Sentinel Initiative - An Evolving National Resource.." The New England journal of medicine 379.22 (November, 2018): 2091-2093. [doi]
  56. Sharma, A; Harrington, RA; McClellan, MB; Turakhia, MP; Eapen, ZJ; Steinhubl, S; Mault, JR; Majmudar, MD; Roessig, L; Chandross, KJ; Green, EM; Patel, B; Hamer, A; Olgin, J; Rumsfeld, JS; Roe, MT; Peterson, ED. "Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care.." J Am Coll Cardiol 71.23 (June, 2018): 2680-2690. [doi]  [abs]
  57. Wong, CA; Perrin, JM; McClellan, M. "Making the Case for Value-Based Payment Reform in Children's Health Care.." JAMA Pediatr 172.6 (June, 2018): 513-514. [doi]
  58. Engelgau, MM; Narayan, KMV; Ezzati, M; Salicrup, LA; Belis, D; Aron, LY; Beaglehole, R; Beaudet, A; Briss, PA; Chambers, DA; Devaux, M; Fiscella, K; Gottlieb, M; Hakkinen, U; Henderson, R; Hennis, AJ; Hochman, JS; Jan, S; Koroshetz, WJ; Mackenbach, JP; Marmot, MG; Martikainen, P; McClellan, M; Meyers, D; Parsons, PE; Rehnberg, C; Sanghavi, D; Sidney, S; Siega-Riz, AM; Straus, S; Woolf, SH; Constant, S; Creazzo, TL; de Jesus, JM; Gavini, N; Lerner, NB; Mishoe, HO; Nelson, C; Peprah, E; Punturieri, A; Sampson, U; Tracy, RL; Mensah, GA. "Implementation Research to Address the United States Health Disadvantage: Report of a National Heart, Lung, and Blood Institute Workshop.." Global heart 13.2 (June, 2018): 65-72. [doi]  [abs]
  59. Daniel, GW; Schneider, M; Lopez, MH; McClellan, MB. "Implementation of a Market Entry Reward within the United States.." The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 46.1_suppl (June, 2018): 50-58. [doi]  [abs]
  60. Aronson, S; Sangvai, D; McClellan, MB. "Why a Proactive Perioperative Medicine Policy Is Crucial for a Sustainable Population Health Strategy.." Anesth Analg 126.2 (February, 2018): 710-712. [doi]
  61. Nussbaum, S; McClellan, M; Metlay, G. "Principles for a Framework for Alternative Payment Models.." JAMA 319.7 (February, 2018): 653-654. [doi]
  62. Alexander, JH; Corrigan-Curay, J; McClellan, M. "The Clinical Trials Transformation Initiative: Looking back, looking forward.." Clin Trials 15.1_suppl (February, 2018): 3-4. [doi]
  63. McClellan, M; Japinga, M. "The Affordable Care Act: What's Next?." Annual review of medicine 69.1 (January, 2018): 41-52. [doi]  [abs]
  64. Farmer, SA; Casale, PN; Gillam, LD; Rumsfeld, JS; Erickson, S; Kirschner, NM; de Regnier, K; Williams, BR; Martin, RS; McClellan, MB. "Payment Reform to Enhance Collaboration of Primary Care and Cardiology: A Review.." JAMA cardiology 3.1 (January, 2018): 77-83. [doi]  [abs]
  65. Gajewski, JL; McClellan, MB; Majhail, NS; Hari, PN; Bredeson, CN; Maziarz, RT; LeMaistre, CF; Lill, MC; Farnia, SH; Komanduri, KV; Boo, MJ. "Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients.." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 24.1 (January, 2018): 4-12. [doi]  [abs]
  66. Maru, D; Maru, S; Nirola, I; Gonzalez-Smith, J; Thoumi, A; Nepal, P; Chaudary, P; Basnett, I; Udayakumar, K; McClellan, M. "Accountable Care Reforms Improve Women's And Children's Health In Nepal.." Health affairs (Project Hope) 36.11 (November, 2017): 1965-1972. [doi]  [abs]
  67. McClellan, M; Udayakumar, K; Thoumi, A; Gonzalez-Smith, J; Kadakia, K; Kurek, N; Abdulmalik, M; Darzi, AW. "Improving Care And Lowering Costs: Evidence And Lessons From A Global Analysis Of Accountable Care Reforms.." Health affairs (Project Hope) 36.11 (November, 2017): 1920-1927. [doi]  [abs]
  68. Japinga, M; Saunders, R; Gellad, ZF; McClellan, M. "The Evolving Payment Reform Landscape: New Opportunities for Gastroenterology Leadership.." Clin Gastroenterol Hepatol 15.9 (September, 2017): 1322-1325. [doi]
  69. Daniel, GW; Schneider, M; McClellan, MB. "Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award.." JAMA 318.12 (September, 2017): 1103-1104. [doi]
  70. Dzau, VJ; McClellan, MB; McGinnis, JM; Burke, SP; Coye, MJ; Diaz, A; Daschle, TA; Frist, WH; Gaines, M; Hamburg, MA; Henney, JE; Kumanyika, S; Leavitt, MO; Parker, RM; Sandy, LG; Schaeffer, LD; Steele, GD; Thompson, P; Zerhouni, E. "Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative.." JAMA 317.14 (April, 2017): 1461-1470. [doi]  [abs]
  71. Fraiche, AM; Eapen, ZJ; McClellan, MB. "Moving Beyond the Walls of the Clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure.." JACC Heart Fail 5.4 (April, 2017): 297-304. [doi]  [abs]
  72. McGlynn, EA; McClellan, M. "Strategies For Assessing Delivery System Innovations.." Health affairs (Project Hope) 36.3 (March, 2017): 408-416. [doi]  [abs]
  73. Shrank, WH; Saunders, RS; McClellan, M. "Better Evidence to Guide Payment Reforms: Recognizing the Importance of Perspective.." JAMA 317.8 (February, 2017): 805-806. [doi]
  74. Sorenson, C; Lavezzari, G; Daniel, G; Burkholder, R; Boutin, M; Pezalla, E; Sanders, G; McClellan, M. "Advancing Value Assessment in the United States: A Multistakeholder Perspective.." Value Health 20.2 (February, 2017): 299-307. [doi]  [abs]
  75. Farmer, SA; Darling, ML; George, M; Casale, PN; Hagan, E; McClellan, MB. "Existing and Emerging Payment and Delivery Reforms in Cardiology.." JAMA cardiology 2.2 (February, 2017): 210-217. [doi]  [abs]
  76. Valuck, T; Blaisdell, D; Dugan, DP; Westrich, K; Dubois, RW; Miller, RS; McClellan, M. "Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures.." Journal of managed care & specialty pharmacy 23.2 (February, 2017): 174-181. [doi]  [abs]
  77. Zineh, I; Abernethy, D; Hop, C; Bello, A; McClellan, MB; Daniel, GW; Romine, MH. "Improving the tools of clinical pharmacology: Goals for 2017 and beyond.." Clinical pharmacology and therapeutics 101.1 (January, 2017): 22-24. [doi]  [abs]
  78. Audibert, C; Romine, M; Caze, A; Daniel, G; Leff, J; McClellan, M. "Building a drug development database: challenges in reliable data availability.." Drug development and industrial pharmacy 43.1 (January, 2017): 74-78. [doi]  [abs]
  79. Feinberg, DT; McClellan, MB. "More Value From Payment Reform in Health Care and Biomedical Innovation.." JAMA 316.16 (October, 2016): 1653-1654. [doi]
  80. McClellan, MB; Leavitt, MO. "Competencies and Tools to Shift Payments From Volume to Value.." JAMA 316.16 (October, 2016): 1655-1656. [doi]
  81. Dzau, VJ; McClellan, M; McGinnis, JM. "Vital Directions for Health and Health Care: An Initiative of the National Academy of Medicine.." JAMA 316.7 (August, 2016): 711-712. [doi]
  82. Farmer, SA; Shalowitz, J; George, M; McStay, F; Patel, K; Perrin, J; Moghtaderi, A; McClellan, M. "Fully Capitated Payment Breakeven Rate for a Mid-Size Pediatric Practice.." Pediatrics 138.2 (August, 2016): e20154367. [doi]  [abs]
  83. Pines, JM; McStay, F; George, M; Wiler, JL; McClellan, M. "Aligning payment reform and delivery innovation in emergency care.." The American journal of managed care 22.8 (August, 2016): 515-518.  [abs]
  84. Clough, JD; McClellan, M. "Implementing MACRA: Implications for Physicians and for Physician Leadership.." JAMA 315.22 (June, 2016): 2397-2398. [doi]
  85. Patel, K; Presser, E; George, M; McClellan, M. "Shifting Away From Fee-For-Service: Alternative Approaches to Payment in Gastroenterology.." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 14.4 (April, 2016): 497-506. [doi]  [abs]
  86. McClellan, MB; Sigal, EV. "The 21st Century Cures Act.." The New England journal of medicine 373.17 (October, 2015): 1677-1678. [doi]
  87. Valuck, T; Dugan, D; Dubois, RW; Westrich, K; Penso, J; McClellan, M. "Solutions for filling gaps in accountable care measure sets.." The American journal of managed care 21.10 (October, 2015): 723-728.  [abs]
  88. Thoumi, A; Udayakumar, K; Drobnick, E; Taylor, A; McClellan, M. "Innovations In Diabetes Care Around the World: Case Studies Of Care Transformation Through Accountable Care Reforms.." Health affairs (Project Hope) 34.9 (September, 2015): 1489-1497. [doi]  [abs]
  89. Sanghavi, D; Samuels, K; George, M; Patel, K; Bleiberg, S; McStay, F; Thoumi, A; McClellan, M. "Case study: Transforming cancer care at a community oncology practice.." Healthcare (Amsterdam, Netherlands) 3.3 (September, 2015): 160-168. [doi]  [abs]
  90. McClellan, M. "Accountable care organizations and evidence-based payment reform.." JAMA 313.21 (June, 2015): 2128-2130. [doi]
  91. Patel, K; Thoumi, A; Nadel, J; O'Shea, J; McClellan, M. "Transforming oncology care: payment and delivery reform for person-centered care.." The American journal of managed care 21.5 (May, 2015): 388-393.
  92. McClellan, MB; Daniel, GW; Dickson, D; Perlmutter, J; Berger, DP; Miller, V; Nussbaum, S; Malin, J; Romine, MH; Schilsky, RL. "Improving evidence developed from population-level experience with targeted agents.." Clinical pharmacology and therapeutics 97.5 (May, 2015): 478-487. [doi]  [abs]
  93. McClellan, MB; Thoumi, AI. "Oncology payment reform to achieve real health care reform.." Journal of oncology practice 11.3 (May, 2015): 223-230. [doi]  [abs]
  94. Outterson, K; Powers, JH; Daniel, GW; McClellan, MB. "Repairing the broken market for antibiotic innovation.." Health affairs (Project Hope) 34.2 (February, 2015): 277-285. [doi]  [abs]
  95. Daniel, GW; Cazé, A; Romine, MH; Audibert, C; Leff, JS; McClellan, MB. "Improving pharmaceutical innovation by building a more comprehensive database on drug development and use.." Health affairs (Project Hope) 34.2 (February, 2015): 319-327. [doi]  [abs]
  96. Mostashari, F; Sanghavi, D; McClellan, M. "Primary care physician-led health reform--reply.." JAMA 312.14 (October, 2014): 1472. [doi]
  97. McClellan, M; Kent, J; Beales, SJ; Cohen, SIA; Macdonnell, M; Thoumi, A; Abdulmalik, M; Darzi, A. "Accountable care around the world: a framework to guide reform strategies.." Health affairs (Project Hope) 33.9 (September, 2014): 1507-1515. [doi]  [abs]
  98. Wachter, B; McClellan, M; McKinney, M. "Wachter, McClellan offer takes on measuring quality.." Modern healthcare 44.28 (July, 2014): 35-36.
  99. McClellan, M; Sigal, E. "New FDA breakthrough-drug category--implications for patients.." The New England journal of medicine 371.1 (July, 2014): 87-88. [doi]
  100. Mostashari, F; Sanghavi, D; McClellan, M. "Health reform and physician-led accountable care: the paradox of primary care physician leadership.." JAMA 311.18 (May, 2014): 1855-1856. [doi]
  101. McClellan, M; Patel, K; Sanghavi, D. "Medicare physician payment reform: will 2014 be the fix for SGR?." JAMA 311.7 (February, 2014): 669-670. [doi]
  102. McClellan, M; Goozner, M. "Moving physicians from fee-for-service first step to 'doc fix,' mcClellan says.." Modern healthcare 44.8 (February, 2014): 30.
  103. Daniel, GW; Rubens, EK; McClellan, M. "Coverage with evidence development for Medicare beneficiaries: challenges and next steps.." JAMA internal medicine 173.14 (July, 2013): 1281-1282. [doi]
  104. Kocot, SL; Dang-Vu, C; White, R; McClellan, M. "Early experiences with accountable care in Medicaid: special challenges, big opportunities.." Population health management 16 Suppl 1 (January, 2013): S4-11. [doi]  [abs]
  105. Patel, KK; Morin, AJ; Nadel, JL; McClellan, MB. "Meaningful physician payment reform in oncology." Journal of Oncology Practice 9.6 SUPPL. (January, 2013). [doi]  [abs]
  106. McClellan, M. "Mark McClellan. Interview by Asher Mullard.." Nature reviews. Drug discovery 11.9 (September, 2012): 668. [doi]
  107. Naylor, MD; Kurtzman, ET; Grabowski, DC; Harrington, C; McClellan, M; Reinhard, SC. "Unintended consequences of steps to cut readmissions and reform payment may threaten care of vulnerable older adults.." Health affairs (Project Hope) 31.7 (July, 2012): 1623-1632. [doi]  [abs]
  108. McClellan, M. "Implementation through collaboration: The Brookings-Dartmouth ACO Learning Network.." Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society 13.2 (January, 2012): 15-16.
  109. Fisher, ES; McClellan, MB; Safran, DG. "Building the path to accountable care.." The New England journal of medicine 365.26 (December, 2011): 2445-2447. [doi]
  110. Roberts, SA; Karnes, EK; Allen, JD; Benner, JS; Sigal, EV; McClellan, M. "Achieving the goals of effective, safe, and individualized cancer care.." Clinical cancer research : an official journal of the American Association for Cancer Research 17.21 (November, 2011): 6632-6633. [doi]
  111. Roski, J; McClellan, M. "Measuring health care performance now, not tomorrow: essential steps to support effective health reform.." Health affairs (Project Hope) 30.4 (April, 2011): 682-689. [doi]  [abs]
  112. Behrman, RE; Benner, JS; Brown, JS; McClellan, M; Woodcock, J; Platt, R. "Developing the sentinel system - A national resource for evidence development." New England Journal of Medicine 364.6 (February, 2011): 498-499. [doi]
  113. McClellan, M; Benner, J; Schilsky, R; Epstein, D; Woosley, R; Friend, S; Sidransky, D; Geoghegan, C; Kessler, D. "An accelerated pathway for targeted cancer therapies.." Nature reviews. Drug discovery 10.2 (February, 2011): 79-80. [doi]  [abs]
  114. Antos, J; Bertko, J; Chernew, M; Cutler, D; de Brantes, F; Goldman, D; Kocher, B; McClellan, M; McGlynn, E; Pauly, M; Shortell, S. "Bending the curve through health reform implementation.." The American journal of managed care 16.11 (November, 2010): 804-812.  [abs]
  115. Benner, JS; Morrison, MR; Karnes, EK; Kocot, SL; McClellan, M. "An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.." Health affairs (Project Hope) 29.10 (October, 2010): 1768-1776. [doi]  [abs]
  116. Tunis, SR; Benner, J; McClellan, M. "Comparative effectiveness research: Policy context, methods development and research infrastructure.." Statistics in medicine 29.19 (August, 2010): 1963-1976. [doi]  [abs]
  117. Williams, DR; McClellan, MB; Rivlin, AM. "Beyond the Affordable Care Act: achieving real improvements in Americans' health.." Health affairs (Project Hope) 29.8 (August, 2010): 1481-1488. [doi]  [abs]
  118. McClellan, M; McKethan, AN; Lewis, JL; Roski, J; Fisher, ES. "A national strategy to put accountable care into practice.." Health affairs (Project Hope) 29.5 (May, 2010): 982-990. [doi]  [abs]
  119. Schilsky, RL; Allen, J; Benner, J; Sigal, E; McClellan, M. "Commentary: tackling the challenges of developing targeted therapies for cancer.." The oncologist 15.5 (January, 2010): 484-487. [doi]
  120. Antos, J; Bertko, J; Chernew, M; Cutler, D; Goldman, D; McClellan, M; McGlynn, E; Pauly, M; Schaeffer, L; Shortell, S. "Bending the curve: effective steps to address long-term healthcare spending growth.." The American journal of managed care 15.10 (October, 2009): 676-680.
  121. Bech, M; Christiansen, T; Dunham, K; Lauridsen, J; Lyttkens, CH; McDonald, K; McGuire, A; TECH Investigators. "The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks.." Health economics 18.10 (October, 2009): 1114-1132. [doi]  [abs]
  122. Platt, R; Wilson, M; Chan, KA; Benner, JS; Marchibroda, J; McClellan, M. "The new Sentinel Network--improving the evidence of medical-product safety.." The New England journal of medicine 361.7 (August, 2009): 645-647. [doi]
  123. McClellan, M; Benner, JS. "Four important steps toward 21st century care for patients with cancer.." The oncologist 14.4 (April, 2009): 313-316. [doi]
  124. Fisher, ES; McClellan, MB; Bertko, J; Lieberman, SM; Lee, JJ; Lewis, JL; Skinner, JS. "Fostering accountable health care: moving forward in medicare.." Health affairs (Project Hope) 28.2 (March, 2009): w219-w231. [doi]  [abs]
  125. McClellan, M. "Mark McClellan, MD, PhD addressing the quality challenge.." Healthcare financial management : journal of the Healthcare Financial Management Association 62.2 (February, 2008): 48-51.
  126. Garber, AM; McClellan, MB. "Satisfaction guaranteed--"payment by results" for biologic agents.." The New England journal of medicine 357.16 (October, 2007): 1575-1577. [doi]
  127. McClellan, M. "Money no excuse for hampering progress. Interview by Rebecca Allmark.." The Health service journal 117.6066 (July, 2007): 18-19.
  128. McClellan, M. "Achieving value-driven health care.." AHIP Coverage 48.4 (July, 2007): 34-passim.
  129. McClellan, M. "Drug safety reform at the FDA--pendulum swing or systematic improvement?." The New England journal of medicine 356.17 (April, 2007): 1700-1702. [doi]
  130. Bach, PB; McClellan, MB. "The first months of the prescription-drug benefit--a CMS update.." The New England journal of medicine 354.22 (June, 2006): 2312-2314. [doi]
  131. Garson, A; Yong, CM; Yock, CA; McClellan, MB. "International differences in patient and physician perceptions of "high quality" healthcare: a model from pediatric cardiology.." The American journal of cardiology 97.7 (April, 2006): 1073-1075. [doi]  [abs]
  132. McClellan, M; Skinner, J. "The incidence of Medicare." Journal of Public Economics 90.1-2 (January, 2006): 257-276. [doi]  [abs]
  133. Bach, PB; McClellan, MB. "A prescription for a modern Medicare program.." The New England journal of medicine 353.26 (December, 2005): 2733-2735. [doi]
  134. McClellan, MB. "Medicare Part D prescription coverage: what it means for primary care physicians.." Geriatrics 60.10 (October, 2005): 7-9.
  135. Skinner, J; Chandra, A; Staiger, D; Lee, J; McClellan, M. "Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients.." Circulation 112.17 (October, 2005): 2634-2641. [doi]  [abs]
  136. McClellan, M. "Help your patients become aware of the new medicare prescription drug plans.." The oncologist 10.8 (September, 2005): 563-564. [doi]
  137. McClellan, M. "The challenge of implementing the new Medicare drug benefit while updating physicians' pay.." Bulletin of the American College of Surgeons 90.9 (September, 2005): 18-19.
  138. Nash, I. "Implantable cardioverter-defibrillators.." N Engl J Med 352.19 (May, 2005): 2022-2025.
  139. McClellan, MB. "Medicare Part D: opportunities and challenges for pharmacy.." Journal of the American Pharmacists Association : JAPhA 45.3 (May, 2005): 328-335. [doi]
  140. McClellan, MB; Loeb, JM; Clancy, CM; Francis, GS; Jacobs, AK; Kizer, KW; O'Kane, ME; Wolk, MJ. "Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.." Annals of internal medicine 142.5 (March, 2005): 386-387. [doi]
  141. McClellan, MB; Tunis, SR. "Medicare coverage of ICDs.." The New England journal of medicine 352.3 (January, 2005): 222-224. [doi]
  142. Becker, D; Kessler, D; McClellan, M. "Detecting Medicare abuse.." Journal of health economics 24.1 (January, 2005): 189-210. [doi]  [abs]
  143. McClellan, MB. "Use of outcomes research in assuring patient safety and quality care, second plenary session, ISPOR 8th annual international meeting, Arlington, VA, USA.." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 7.5 (September, 2004): 529-534. [doi]
  144. McClellan, M. "Think globally, protect locally: a conversation with Mark McClellan.." Health affairs (Project Hope) 23.3 (May, 2004): 177-185. [doi]  [abs]
  145. Barnato, AE; McClellan, MB; Kagay, CR; Garber, AM. "Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.." Health services research 39.2 (April, 2004): 363-375. [doi]  [abs]
  146. Buntin, MB; Garber, AM; McClellan, M; Newhouse, JP. "The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans.." Health services research 39.1 (February, 2004): 111-130. [doi]  [abs]
  147. McClellan, MB. "Fifth Annual David A. Winston Lecture.." Journal of Health Administration Education 21.1 (January, 2004): 3-14.
  148. McClellan, MB. "Medicare's new drug discount card.." Hospital Outlook 7.2 (January, 2004): 11.
  149. McClellan, M. "Interview with Mark McClellan, MD, PhD." Virtual Mentor 6.1 (January, 2004): 46-47. [doi]
  150. McClellan, MB. "FDA: protecting and advancing America's health.." Health matrix (Cleveland, Ohio : 1991) 14.2 (January, 2004): 357-370.
  151. Kessler, DP; McClellan, MB. "Advance directives and medical treatment at the end of life.." Journal of health economics 23.1 (January, 2004): 111-127. [doi]  [abs]
  152. McClellan, M; Baicker, K. "Reducing uninsurance through the nongroup market: Health insurance credits and purchasing groups." Health Affairs 22.SUPPL. (December, 2003): W363-W366.  [abs]
  153. Pilote, L; Saynina, O; Lavoie, F; McClellan, M. "Cardiac procedure use and outcomes in elderly patients with acute myocardial infarction in the United States and Quebec, Canada, 1988 to 1994.." Medical care 41.7 (July, 2003): 813-822. [doi]  [abs]
  154. Dranove, D; Kessler, D; McClellan, M; Satterthwaite, M. "Is more information better? The effects of "Report Cards" on health care providers." Journal of Political Economy 111.3 (June, 2003): 555-588. [doi]  [abs]
  155. Gould, MK; Sanders, GD; Barnett, PG; Rydzak, CE; Maclean, CC; McClellan, MB; Owens, DK. "Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.." Ann Intern Med 138.9 (May, 2003): 724-735. [doi]  [abs]
  156. McClellan, MB. "Mission: promoting, protecting the public health. FDA Commissioner Mark B. McClellan. Interview by Ray Formanek Jr.." FDA consumer 37.2 (March, 2003): 12-17.
  157. Feigal, DW; Gardner, SN; McClellan, M. "Ensuring safe and effective medical devices.." The New England journal of medicine 348.3 (January, 2003): 191-192. [doi]
  158. McClellan, MB. "From the Food and Drug Administration.." JAMA 288.17 (November, 2002): 2112. [doi]
  159. Kessler, DP; McClellan, MB. "How liability law affects medical productivity.." Journal of health economics 21.6 (November, 2002): 931-955. [doi]  [abs]
  160. Shlipak, MG; Heidenreich, PA; Noguchi, H; Chertow, GM; Browner, WS; McClellan, MB. "Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.." Annals of internal medicine 137.7 (October, 2002): 555-562. [doi]  [abs]
  161. McDonald, KM; Hlatky, MA; Saynina, O; Geppert, J; Garber, AM; McClellan, MB. "Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.." American heart journal 144.3 (September, 2002): 413-421. [doi]  [abs]
  162. Hlatky, MA; Saynina, O; McDonald, KM; Garber, AM; McClellan, MB. "Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.." American heart journal 144.3 (September, 2002): 397-403. [doi]  [abs]
  163. Emanuel, EJ; Ash, A; Yu, W; Gazelle, G; Levinsky, NG; Saynina, O; McClellan, M; Moskowitz, M. "Managed care, hospice use, site of death, and medical expenditures in the last year of life.." Archives of internal medicine 162.15 (August, 2002): 1722-1728. [doi]  [abs]
  164. Heidenreich, PA; Shlipak, MG; Geppert, J; McClellan, M. "Racial and sex differences in refusal of coronary angiography.." The American journal of medicine 113.3 (August, 2002): 200-207. [doi]  [abs]
  165. McClellan, M; Baicker, K. "Reducing uninsurance through the nongroup market: health insurance credits and purchasing groups.." Health affairs (Project Hope) Suppl Web Exclusives (July, 2002): W363-W366. [doi]  [abs]
  166. Kessler, D; McClellan, M. "Malpractice law and health care reform: Optimal liability policy in an era of managed care." Journal of Public Economics 84.2 (May, 2002): 175-197. [doi]  [abs]
  167. Weiss, JP; Saynina, O; McDonald, KM; McClellan, MB; Hlatky, MA. "Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.." The American journal of medicine 112.7 (May, 2002): 519-527. [doi]  [abs]
  168. Heidenreich, PA; McClellan, M; Frances, C; Baker, LC. "The relation between managed care market share and the treatment of elderly fee-for-service patients with myocardial infarction.." The American journal of medicine 112.3 (February, 2002): 176-182. [doi]  [abs]
  169. Cutler, DM; McClellan, M. "Is technological change in medicine worth it?." Health affairs (Project Hope) 20.5 (September, 2001): 11-29. [doi]  [abs]
  170. "Technological change around the world: evidence from heart attack care.." Health affairs (Project Hope) 20.3 (May, 2001): 25-42. [doi]  [abs]
  171. Shlipak, MG; Browner, WS; Noguchi, H; Massie, B; Frances, CD; McClellan, M. "Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.." The American journal of medicine 110.6 (April, 2001): 425-433. [doi]  [abs]
  172. Heidenreich, PA; McClellan, M. "Trends in treatment and outcomes for acute myocardial infarction: 1975-1995.." The American journal of medicine 110.3 (February, 2001): 165-174. [doi]  [abs]
  173. Cutler, DM; McClellan, M. "Productivity change in health care." American Economic Review 91.2 (January, 2001): 281-286. [doi]
  174. Baker, LC; Mcclellan, MB. "Managed care, health care quality, and regulation." Journal of Legal Studies 30.2 PART II (January, 2001): 715. [doi]  [abs]
  175. McClellan, MB; Newhouse, JP. "Overview of the special supplement issue.." Health services research 35.5 Pt 2 (December, 2000): 1061-1069.
  176. Frances, CD; Shlipak, MG; Noguchi, H; Heidenreich, PA; McClellan, M. "Does physician specialty affect the survival of elderly patients with myocardial infarction?." Health services research 35.5 Pt 2 (December, 2000): 1093-1116.  [abs]
  177. Frances, CD; Noguchi, H; Massie, BM; Browner, WS; McClellan, M. "Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.." Archives of internal medicine 160.17 (September, 2000): 2645-2650. [doi]  [abs]
  178. McClellan, M; Spatz, ID; Carney, S. "Designing a Medicare prescription drug benefit: issues, obstacles, and opportunities.." Health affairs (Project Hope) 19.2 (March, 2000): 26-41. [doi]  [abs]
  179. McClellan, M. "Medicare reform: fundamental problems, incremental steps.." The journal of economic perspectives : a journal of the American Economic Association 14.2 (January, 2000): 21-44. [doi]  [abs]
  180. Kessler, DP; McClellan, MB. "Is hospital competition socially wasteful?." Quarterly Journal of Economics 115.2 (January, 2000): 577-615. [doi]  [abs]
  181. Brooks, JM; McClellan, M; Wong, HS. "The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter?." Inquiry : a journal of medical care organization, provision and financing 37.1 (January, 2000): 75-90.  [abs]
  182. Cutler, DM; McClellan, M; Newhouse, JP. "How does managed care do it?." The Rand journal of economics 31.3 (January, 2000): 526-548. [doi]  [abs]
  183. McClellan, M; Kessler, D. "Spending growth rates: are the differences real?." Health affairs (Project Hope) 18.6 (November, 1999): 250-252. [doi]
  184. McClellan, M; Kessler, D. "A global analysis of technological change in health care: the case of heart attacks. The TECH Investigators.." Health affairs (Project Hope) 18.3 (May, 1999): 250-255. [doi]
  185. McClellan, M; Skinner, J. "Medicare reform: who pays and who benefits?." Health affairs (Project Hope) 18.1 (January, 1999): 48-62. [doi]  [abs]
  186. Hornberger, J; Best, J; Geppert, J; McClellan, M. "Risks and costs of end-stage renal disease after heart transplantation.." Transplantation 66.12 (December, 1998): 1763-1770. [doi]  [abs]
  187. McClellan, M; Noguchi, H. "Technological Change in Heart-Disease Treatment: Does High Tech Mean Low Value?." American Economic Review 88.2 (May, 1998): 90-96.
  188. Cutler, DM; McClellan, M; Newhouse, JP. "What Has Increased Medical-Care Spending Bought?." American Economic Review 88.2 (May, 1998): 132-136.
  189. Cutler, DM; McClellan, M; Newhouse, JP; Remler, D. "Are medical prices declining? Evidence from heart attack treatments." Quarterly Journal of Economics 113.4 (January, 1998): 991-1024. [doi]  [abs]
  190. Newhouse, JP; McClellan, M. "Econometrics in outcomes research: the use of instrumental variables.." Annual review of public health 19 (January, 1998): 17-34. [doi]  [abs]
  191. McClellan, M; Newhouse, JP. "The marginal cost-effectiveness of medical technology: A panel instrumental-variables approach." Journal of Econometrics 77.1 (January, 1997): 39-64. [doi]  [abs]
  192. McClellan, M. "Hospital reimbursement incentives: An empirical analysis." Journal of Economics and Management Strategy 6.1 (January, 1997): 91-128. [doi]  [abs]
  193. McClellan, M. "Are the returns to technological change in health care declining?." Proceedings of the National Academy of Sciences of the United States of America 93.23 (November, 1996): 12701-12708. [doi]  [abs]
  194. Kessler, D; McClellan, M. "Do doctors practice defensive medicine?." Quarterly Journal of Economics 111.2 (January, 1996): 352-390. [doi]  [abs]
  195. McClellan, M. "Uncertainty, health-care technologies, and health-care choices.." The American economic review 85.2 (May, 1995): 38-44.
  196. McClellan, M. "The uncertain demand for medical care a comment on Emmett Keeler." Journal of Health Economics 14.2 (January, 1995): 239-242. [doi]
  197. Mcclellan, MB; Newhouse, JP; Mcneil, BJ. "Catheterization and Mortality in Elderly Patients With Acute Myocardial Infarction-Reply." JAMA the Journal of the American Medical Association 273.17 (January, 1995): 1333. [doi]  [abs]
  198. McClellan, M; McNeil, BJ; Newhouse, JP. "Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.." JAMA 272.11 (September, 1994): 859-866. [doi]  [abs]
  199. McClellan, M; Brook, RH. "Appropriateness of care. A comparison of global and outcome methods to set standards.." Medical care 30.7 (July, 1992): 565-586.  [abs]

Chapters in Books

  1. Dzau, VJ; Ginsburg, GS; Chopra, A; Goldman, D; Green, ED; Leonard, DGB; McClellan, MB; Plump, A; Terry, SF; Yamamoto, KR. "Realizing the full potential of precision medicine in health and health care." Vital Directions for Health Health Care an Initiative of the National Academy of Medicine. September, 2023: 249-268.
  2. Dzau, VJ; McClellan, MB; Burke, SP; Coye, MJ; Daschle, TA; Diaz, A; Frist, WH; Gaines, ME; Hamburg, MA; Henney, JE; Kumanyika, SK; Leavitt, MO; McGinnis, JM; Parker, RM; Sandy, LG; Schaeffer, LD; Steele, GD; Thompson, P; Zerhouni, EA. "Vital directions for health and health care: Priorities from a national academy of medicine initiative." Vital Directions for Health Health Care an Initiative of the National Academy of Medicine. September, 2023: 1-39.
  3. Leavitt, MO; McClellan, MB; Devore, SD; Fisher, E; Gilfillan, RJ; Lieber, HS; Merkin, R; Rideout, J; Thiry, KJ. "Competencies and tools to shift payments from volume to value." Vital Directions for Health Health Care an Initiative of the National Academy of Medicine. September, 2023: 221-231.
  4. McClellan, MB; Feinberg, DT; Bach, PB; Chew, P; Conway, P; Leschly, N; Marchand, G; Mussallem, MA; Teeter, D. "Payment reform for better value and medical innovation." Vital Directions for Health Health Care an Initiative of the National Academy of Medicine. September, 2023: 191-219.
  5. McClellan, M; Rajkumar, R; Couch, M; Holder, D; Long, P; Medows, R; Navathe, A; Pham, M; Sandy, L; Shrank, W; Smith, M. "HEALTH CARE PAYERS COVID-19 IMPACT ASSESSMENT: LESSONS LEARNED AND COMPELLING NEEDS." Emerging Stronger from Covid 19 Priorities for Health System Transformation. January, 2023: 283-333. [doi]
  6. Abernethy, A; Balser, J; Clancy, C; Desalvo, K; Goodrich, K; Hughes, R; Isasi, F; Lee, P; Madara, J; Mammen, M; McClellan, M; Miyamoto, S; Narasimhan, V; Naylor, M; Rajkumar, R; Ryu, J; Skorton, D. "HEALTH SYSTEM TRANSFORMATION: COMMON PRIORITIES ACROSS SECTORS." Emerging Stronger from Covid 19 Priorities for Health System Transformation. January, 2023: 473-542. [doi]
  7. Adil, SM; Charalambous, LT; Spears, CA; Kiyani, M; Hodges, SE; Yang, Z; Lee, HJ; Rahimpour, S; Parente, B; Greene, KA; McClellan, M; Lad, SP. "Impact of Spinal Cord Stimulation on Opioid Dose Reduction: A Nationwide Analysis."  December, 2021: S73. [doi]
  8. McClellan, M. "Reforming payments to healthcare providers: the key to slowing healthcare cost growth while improving quality?."  January, 2011: 69-92. [doi]  [abs]
  9. McClellan, MB; Kiecolt-Glaser, J; Mintz, S; O'Dell, ML; Barrett, C. "I. impact of the age wave and chronic disease in the next generation."  December, 2007: S4-S6.
  10. McClellan, MB. "Remarks of the Commissioner of Food and Drugs.."  January, 2003: 191-204.
  11. Kessler, DP; McClellan, MB. "The effects of hospital ownership on medical productivity.."  January, 2002: 488-506. [doi]  [abs]

Policy Briefs

  1. McClellan, M; Silcox, C; Anderson, D; Zavodszky, A; Borre, E; Dentzer, S; Aspinall, M. "A National Decision Point: Effective Testing and Screening for Covid-19."  Duke-Margolis Center for Health Policy/Rockefeller Foundation, September, 2020  [abs]
  2. McClellan, M; Schneider, M; Dentzer, S; Sheehan, S; Silcox, C; Hamilton Lopez, M; Wosinska, M. "From Development to Market: Understanding COVID-19 Testing and Its Challenges."  Duke-Margolis Center for Health Policy, August, 2020  [abs]
  3. McClellan, M; Rivers, C; Silcox, C. "Legislative and Regulatory Steps for a National COVID-19 Testing Strategy."  Duke-Margolis Center for Health Policy, August, 2020  [abs]

Op-eds

  1. McClellan, M; Silcox, C; Roades, T; Thoumi, A. Testing as an Alternative to Quarantining: Key Considerations and Best Practices for Implementing Test to Stay.  Duke-Margolis Center for Health Policy (January, 2022).
  2. McClellan, M; Slavitt, A; Green, P. We both led Medicare and Medicaid. Biden’s vaccine mandate for health-care workers must stand..  Washington Post (January, 2022).
  3. McClellan, M; Dzau, V; McGinness, M; Marx, J; Sullenger, R; ElLaissi, W. Vital Directions For Health And Health Care: Priorities For 2021.  Health Affairs (January, 2021).
  4. McClellan, M; Gottlieb, S. A Light Regulatory Touch to Keep Covid Drugs Current.  Wall Street journal (Eastern ed.) (January, 2021).
  5. McClellan, M; Gottlieb, S. Why Are Covid Antibody Drugs Sitting on Shelves?.  Wall Street journal (Eastern ed.) (December, 2020).
  6. McClellan, M; Sandhu, S; Saunders, R; Wong, C. Health Equity Should Be A Key Value In Value-Based Payment And Delivery Reform.  Health Affairs (November, 2020).
  7. McClellan, M; Gottlieb, S. You Can Trust the FDA’s Vaccine Process.  Wall Street journal (Eastern ed.) (September, 2020).
  8. McClellan, M; Gottlieb, S. Betting on Better Drug Trials to Beat Covid-19.  Wall Street journal (Eastern ed.) (August, 2020).
  9. McClellan, M; Caitlin Rivers, C; Silcox, C. Legislative and Regulatory Steps for a National COVID-19 Testing Strategy.  August, 2020.
  10. McClellan, M; Hamburg, M; Califf, R; Gottlieb, S. 4 Former FDA Commissioners: Blood plasma might be the covid-19 treatment we need.  August, 2020.
  11. McClellan, M; Sharma, I; Wosinska, M; Sullivan, H; Kroetsch, A. COVID-19 Manufacturing for Monoclonal Antibodies.  August, 2020.
  12. Duke-Margolis Center for Health Policy; Families USA; United States of Care. COVID-19 Health Care Response and Resilience Program.  July, 2020.
  13. McClellan, M; Gottlieb, S. Covid Shows the Need for a Diagnostic Stockpile.  Wall Street journal (Eastern ed.) (July, 2020).
  14. McClellan, M; Gottlieb, S. Reinvent Health Care to Beat COVID-19.  June, 2020.
  15. McClellan, M; Gottlieb, S. Rules for Clinical Trials in a Pandemic.  June, 2020.
  16. McClellan, M; Roiland, R; Japinga, M; Singletary, E; Sharma, I; Gonzalez-Smith, J; Wang, G; Jacobs, J; Bleser, W; Saunders, R. Value-Based Care in the COVID-19 Era: Enabling Health Care Response and Resilience.  June, 2020.
  17. McClellan, M; Crook, H; Saunders, R; Bleser, W; Broome, T; Muhlestein, D. Leveraging Payment Reforms For COVID-19 And Beyond: Recommendations For Medicare ACOs And CMS’s Interim Final Rule.  Health Affairs (May, 2020).
  18. McClellan, M; Slavitt, A. Health leaders: Let’s #OpenSafely.  May, 2020.
  19. McClellan, M; Mostashari, F. Data Interoperability and Exchange to Support COVID-19 Containment.  May, 2020.
  20. McClellan, M; Mostashari, F; Barker, T. Health Care Payment to Support COVID-19 Detection and Containment.  May, 2020.
  21. McClellan, M; Gottlieb, S; Mostashari, F; Rivers, C; Silvis, L. A National COVID-19 Surveillance System: Achieving Containment.  April, 2020.
  22. McClellan, M; Gottlieb, S; Rivers, C; Silvis, L; Watson, C. National coronavirus response: A road map to reopening.  March, 2020.
  23. McClellan, M; Gottlieb, S. Achieving Widespread Availability of Timely and Efficient COVID-19 Testing.  March, 2020.
  24. McClellan, M; Gottlieb, S. Advancing Treatments to Save Lives and Reduce the Risk of COVID-19.  March, 2020.

Mark B McClellan

x